The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
from WebMD Health https://ift.tt/2xWMdBi
via IFTTT
The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
No comments:
Post a Comment